title: Severe prolonged cholestatic hepatitis caused by exemestane.
authors.affiliation: The University of Maryland Marlene and Stewart Greenebaum Cancer Center, S9D, 22 S Greene Street, Baltimore, MD 21201, USA. tbao@umm.edu
authors.forename: Ting
authors.initials: T
authors.lastname: Bao
authors.forename: John
authors.initials: J
authors.lastname: Fetting
authors.forename: Laura
authors.initials: L
authors.lastname: Mumford
authors.forename: Jane
authors.initials: J
authors.lastname: Zorzi
authors.forename: Karineh
authors.initials: K
authors.lastname: Shahverdi
authors.forename: Stacie
authors.initials: S
authors.lastname: Jeter
authors.forename: Frank
authors.initials: F
authors.lastname: Herlong
authors.forename: Vered
authors.initials: V
authors.lastname: Stearns
authors.forename: Linda
authors.initials: L
authors.lastname: Lee
mesh_terms: D000730:Androstadienes / Q000009:adverse effects*; D047072:Aromatase Inhibitors / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D002780:Cholestasis, Intrahepatic / Q000139:chemically induced*; D005260:Female; D006801:Humans; D008875:Middle Aged
chemical_list: D000730:Androstadienes; D047072:Aromatase Inhibitors; C056516:exemestane